Sencare在EASD 2025启动了新的iCan i6 CGM系统,提供15天的穿戴、方便使用和加强糖尿病管理。 Sinocare launched its new iCan i6 CGM system at EASD 2025, offering 15-day wear, easy use, and enhanced diabetes management.

该公司在维也纳的EASD 2025年会议上公布了下一代iCan i6连续葡萄糖监测系统,其中包括15天的穿戴时间、一步式应用和高度补偿。 Sinocare unveiled its next-generation iCan i6 continuous glucose monitoring system at the EASD 2025 conference in Vienna, featuring a 15-day wear time, one-step application, and altitude compensation. 该公司介绍了关于成人和儿童业绩的临床数据,强调了现实世界的可用性,并推出了“A+C”糖尿病预防和控制生态系统,将非侵入性AGMScan筛查与CGM相结合,以便早期发现。 The company presented clinical data on its performance in adults and children, highlighted real-world usability, and introduced the "A+C" Diabetes Prevention and Control Ecosystem, combining non-invasive AGEscan screening with CGM for early detection. 还发现了一种医院葡萄糖管理解决方案,以改善护理协调。 A hospital glucose management solution was also revealed to improve care coordination. 通过伙伴关系,包括与A.Menarini诊断师的伙伴关系, " 中医 " 方案强调,它注重易得的、以病人为中心的糖尿病技术。 Through partnerships, including with A.Menarini Diagnostics, Sinocare emphasized its focus on accessible, patient-centered diabetes technology.